Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Jawahar Mehta to Inflammation

This is a "connection" page, showing publications Jawahar Mehta has written about Inflammation.

 
Connection Strength
 
 
 
4.623
 
  1. Ding Z, Pothineni NVK, Goel A, L?scher TF, Mehta JL. PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1. Cardiovasc Res. 2020 04 01; 116(5):908-915.
    View in: PubMed
    Score: 0.526
  2. Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, Autophagy, and Apoptosis After Myocardial Infarction. J Am Heart Assoc. 2018 04 21; 7(9).
    View in: PubMed
    Score: 0.460
  3. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017 Aug; 11(8):215-225.
    View in: PubMed
    Score: 0.434
  4. Shirazi LF, Bissett J, Romeo F, Mehta JL. Role of Inflammation in Heart Failure. Curr Atheroscler Rep. 2017 Jun; 19(6):27.
    View in: PubMed
    Score: 0.432
  5. Mehta JL, Pothineni NV. Inflammation in Heart Failure: The Holy Grail? Hypertension. 2016 07; 68(1):27-9.
    View in: PubMed
    Score: 0.402
  6. Ding Z, Liu S, Wang X, Theus S, Fan Y, Deng X, Mehta JL. LOX-1 - dependent mitochondrial DNA damage and NLRP3 activation during systemic inflammation in mice. Biochem Biophys Res Commun. 2014 Sep 05; 451(4):637-43.
    View in: PubMed
    Score: 0.356
  7. Lu J, Wang X, Wang W, Muniyappa H, Deshmukh A, Hu C, Das K, Mehta JL. Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. Kidney Int. 2012 Aug; 82(4):436-44.
    View in: PubMed
    Score: 0.309
  8. Mehta JL, Sukhija R, Romeo F, Sepulveda JL. Value of CRP in coronary risk determination. Indian Heart J. 2007 Mar-Apr; 59(2):173-7.
    View in: PubMed
    Score: 0.212
  9. Fahdi IE, Gaddam V, Garza L, Romeo F, Mehta JL. Inflammation, infection, and atherosclerosis. Brain Behav Immun. 2003 Aug; 17(4):238-44.
    View in: PubMed
    Score: 0.166
  10. Pothineni NVK, Rochlani Y, Subramany S, Kovelamudi S, Mehta JL. Hepatic Interactions in Atherosclerotic Heart Disease. Am J Med Sci. 2022 02; 363(2):104-113.
    View in: PubMed
    Score: 0.146
  11. Liu D, Zeng X, Li X, Cui C, Hou R, Guo Z, Mehta JL, Wang X. Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators. Biochem Pharmacol. 2020 05; 175:113863.
    View in: PubMed
    Score: 0.130
  12. Bavineni M, Wassenaar TM, Agnihotri K, Ussery DW, L?scher TF, Mehta JL. Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood. Eur Heart J. 2019 04 07; 40(14):1107-1112.
    View in: PubMed
    Score: 0.123
  13. Ayoub KF, Pothineni NVK, Rutland J, Ding Z, Mehta JL. Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets. Cardiovasc Drugs Ther. 2017 Dec; 31(5-6):593-608.
    View in: PubMed
    Score: 0.112
  14. Ding Z, Liu S, Wang X, Deng X, Fan Y, Sun C, Wang Y, Mehta JL. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxid Redox Signal. 2015 Mar 20; 22(9):760-71.
    View in: PubMed
    Score: 0.092
  15. Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, Mehta JL. Inflammation and atherosclerosis--revisited. J Cardiovasc Pharmacol Ther. 2014 Mar; 19(2):170-8.
    View in: PubMed
    Score: 0.084
  16. Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Mehta JL. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep. 2013; 3:1077.
    View in: PubMed
    Score: 0.080
  17. Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Liu S, Mehta JL. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA. Exp Biol Med (Maywood). 2012 Dec; 237(12):1394-401.
    View in: PubMed
    Score: 0.079
  18. Singla S, Sachdeva R, Mehta JL. Cannabinoids and atherosclerotic coronary heart disease. Clin Cardiol. 2012 Jun; 35(6):329-35.
    View in: PubMed
    Score: 0.075
  19. Yan M, Mehta JL, Zhang W, Hu C. LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications. Cardiovasc Drugs Ther. 2011 Oct; 25(5):451-9.
    View in: PubMed
    Score: 0.073
  20. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007 Jun 08; 100(11):1634-42.
    View in: PubMed
    Score: 0.054
  21. Mehta JL. Oxidized or native low-density lipoprotein cholesterol: which is more important in atherogenesis? J Am Coll Cardiol. 2006 Sep 05; 48(5):980-2.
    View in: PubMed
    Score: 0.051
  22. Mehta JL, Rasouli N, Sinha AK, Molavi B. Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol. 2006; 38(5-6):794-803.
    View in: PubMed
    Score: 0.049
  23. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation. 2004 Jun 29; 109(25 Suppl 1):IV6-19.
    View in: PubMed
    Score: 0.044
  24. Khan MA, Mohammad I, Banerjee S, Tomar A, Varughese KI, Mehta JL, Chandele A, Arockiasamy A. Oxidized LDL receptors: a recent update. Curr Opin Lipidol. 2023 08 01; 34(4):147-155.
    View in: PubMed
    Score: 0.041
  25. Corken A, Ware J, Dai J, Arthur JM, Smyth S, Davis CL, Liu J, Harville TO, Phadnis MA, Mehta JL, Rahmatallah Y, Jain N. Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360. 2022 12 29; 3(12):2036-2047.
    View in: PubMed
    Score: 0.039
  26. Molavi B, Rasouli N, Mehta JL. Peroxisome proliferator-activated receptor ligands as antiatherogenic agents: panacea or another Pandora's box? J Cardiovasc Pharmacol Ther. 2002 Jan; 7(1):1-8.
    View in: PubMed
    Score: 0.037
  27. Khan JA, Cao M, Kang BY, Liu Y, Mehta JL, Hermonat PL. AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol. Atherosclerosis. 2010 Nov; 213(1):59-66.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.